1. Айнабекова Б.А., Баев В.В., Васильев С.А., Воробьев А.П., Воробьев П.А., Воробьева Н.А., и др. Рекомендации по ведению больных с коронавирусной инфекцией COVID-19 в острой фазе и при постковидном синдроме в амбулаторных условиях https://guidelines.mgnot.ru/v2_2021 (10 August 2021) [Ajnabekova BA., Baev V.V., Vasil'ev S.A, Vorob'ev A.P., Vorob'ev P.A., Vorob'eva N.A., et al. Recommendations for the management of patients with COVID-19 coronavirus infection on an outpatient basis in the acute phase and with postcovid syndrome https://guidelines.mgnot.ru/v2_2021 (10 August 2021) (In Russ.)] 2. Авдеев С. М., Адамян Л.В., Алексеева Е.И., Багненко С.Ф., Баранов А.А., Баранова Н.Н., и др. Временные методические рекомендации - профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) Версия 9 (26.10.20) – Министерство здравоохранения Российской Федерации [Avdeev SM., Adamyan L.V., Alekseeva E.I., Bagnenko S.F., Baranov A.A., Baranova N.N., at al. Interim guidelines: prevention, diagnosis and treatment of new coronavirus infection (covid-19). Version 9 (approved by the Ministry of Health of the Russian Federation on 26.10.2020) (In Russ.)] 3. Бевова М.Р., Нетесов С.В., Аульченко Ю.C. Новая коронавирусная инфекция COVID-19. Молекулярная генетика, микробиология и вирусология. 2020;38(2): 51-58. doi: 10.17116/molgen20203802151 [Bevova MR, Netesov SV, Aulchenko YUS. New coronavirus infection COVID-19. Molecular genetics, microbiology and virology.2020;38(2):51-58. doi: 10.17116/molgen20203802151 (In Russ.)] 4. Berechikidze T.T., Pinegin V.B. Telogen effluvium. New possibilities of correction. Russian journal of skin and venereal diseases. 2016; 19(3): 162-166. doi: 10.18821/1560-9588-2016-19-3-162-166 5. Chaolin H., Yeming W., Xingwang L., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395: 497–506. doi.org/10.1016/ S0140- 6736(20)30183-5 6. Chen N., Zhou M., Dong Х., Qu J., Gong F., Han Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507– 513. doi: 10.1016/S0140-6736(20)30211-7 7. Elul M.A, Benjamin L, Singh B., Lant S., Michael B.D., Easton A., et al. Neurological associations of COVID-19. Lancet Neurology. 2020; 19: 767–83. doi: 10.1016/S1474-4422(20)30221-0 8. Garrigues E, Janvier P, Kherabi Y,, Bot A.L., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and healthrelated quality of life after hospitalization for COVID-19. J Infect. 2020; 81:4-6. doi: 10.1016/j.jinf.2020.08.029 9. Jin M., Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases. 2020; 26(7): 1618-1620. doi:10.3201/eid2607.200445 10. Najjar S., Najjar A., Chong D.J, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. Journal of Neuroinflammation. 2020; 17(231): 2-14. doi:10.1186/s12974-020-01896-0 11. Remsik J, Wilcox JA, Babady N.E, McMillen T.A., Vachha B.A., Halpern N.A., et al. Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients. Cancer Cell. 2021; 39(2):276-283. doi: 10.1016/j.ccell.2021.01.007. 12. Seeble J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., et al. Persistent symptoms in adult patients one year after COVID- 19: a prospective cohort study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab611 (05 July 2021) 13. Song E, Zhang C, Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. Preprint 2020; 2020.06.25.169946. doi: 10.1101/2020.06.25.169946 14. Stavem K., Ghanima W., Olsen M.K, Gilboe H.N., Einvik G. Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021; 76(4):405-407. doi: 10.1136/thoraxjnl-2020-216377 15. Vaes А.W., Herck M.V., Meys R., Machado F.V.C., Meys R., Delbressine J.M., et al. Recovery from COVID-19: a sprint or marathon? 6- month follow-up data from online long COVID-19 support groupmember. ERJ Open Res 2021;7(2). doi: 10.1183/23120541.00141-2021 16. Van den Borst B, Peters J.B, Brink M, Schoon Y., Bleeker-Rovers C.P., Schers H., et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clinical Infectious Diseases. Online resource. doi: 10.1093/cid/ciaa1750. 17. Woo M.S, Malsy J, Pöttgen J., Zai S.S., Ufer F., Hadjilaou A., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Communications. 2020;23;2(2):fcaa205. doi: 10.1093/braincomms/fcaa205